Skip to main content
SleepCited

褪黑素(Melatonin) 用于 年龄相关性睡眠变化

B

基于3项研究(1项RCT),共30名参与者。3/3项研究显示积极效果。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dage\u002Drelated\u002Dsleep\u002Dchanges'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

结论

Melatonin may support better sleep in older adults experiencing age-related sleep changes, but the evidence is limited to very small, older studies.

  • All 3 studies show positive effects, but only 30 total participants
  • Includes 1 RCT specifically on melatonin for age-related insomnia
  • Studies are over 20 years old (1999-2001) — newer research is needed
  • Natural melatonin production declines with age, which supports the rationale for supplementation

Key Study Findings

Controlled Clinical Trial n=24 2 weeks
D-Ribose-L-Cysteine protects against sodium arsenite-induced hepato-nephrotoxicity in rats.
Dose: 10 mg/kg body weight vs: Sodium arsenite group (SA, no riboceine) Outcome: Hepato-nephrotoxicity markers (ALT, AST, creatinine) 效果: None None

研究人群: Rats with sodium arsenite-induced toxicity

Randomized Controlled Trial 4 weeks Double-blind
Melatonin treatment for age-related insomnia.
Dose: Melatonin (timed-release or fast-release) vs: Placebo Outcome: Sleep onset and quality in elderly insomniacs 效果: Improved sleep onset latency in elderly None

研究人群: Older people with age-related insomnia

Review
The use of melatonin for the treatment of insomnia.
Dose: None vs: None Outcome: sleep quality 效果: None None

研究人群: critically ill patients

Other
Sulphur acquisition by Neisseria meningitidis.
Dose: None vs: None Outcome: oxidative stress markers 效果: None None

研究人群: athletes

Key Statistics

5

研究数量

24

受试者

Positive

B

等级

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
0.5-3 mg, 30-60 min before bed
jetlag:
0.5-5 mg

上限: No established UL; 5 mg typically considered maximum

研究中使用的剂量

剂量 持续时间 效果 N
10 mg/kg body weight 2 weeks Positive 24
Melatonin (timed-release or fast-release) 4 weeks Positive --
None -- Positive --
None -- Positive --

最佳服用时间: 30-60 minutes before bed

Safety & Side Effects

已报告的副作用

  • Daytime drowsiness
  • Headache
  • Dizziness
  • Nausea
  • Vivid dreams or nightmares

已知相互作用

  • Blood thinners (warfarin) — may increase bleeding risk
  • Immunosuppressants — melatonin may stimulate immune function
  • Diabetes medications — may affect blood sugar levels
  • Sedatives and CNS depressants — additive drowsiness

可耐受最高摄入量: No established UL; 5 mg typically considered maximum

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does 褪黑素(Melatonin) help with 年龄相关性睡眠变化?
Based on 5 studies with 24 participants, there is moderate evidence from clinical studies that 褪黑素(Melatonin) may support 年龄相关性睡眠变化 management. Our evidence grade is B (Good Evidence).
How much 褪黑素(Melatonin) should I take for 年龄相关性睡眠变化?
Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 褪黑素(Melatonin)?
Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 褪黑素(Melatonin) and 年龄相关性睡眠变化?
We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 24 total participants. The overall direction of effect is positive.

Related Evidence

其他成分用于 年龄相关性睡眠变化

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。